Dr. Karen Kelly: What Molecular Markers Do You Routinely Send for in Your Patients with Advanced Non-Small Cell Lung Cancer?
Article
Dr. Karen Kelly describes her thought process on which molecular markers are those clearly indicated for patients with advanced NSCLC, as well as whether smoking status factors into her approach.
[powerpress]